Robert Langer Sells 233,098 Shares of PureTech Health plc (LON:PRTC) Stock

PureTech Health plc (LON:PRTC) insider Robert Langer sold 233,098 shares of the business’s stock in a transaction that occurred on Monday, June 24th. The stock was sold at an average price of GBX 250 ($3.17), for a total value of £582,745 ($739,242.67).

PureTech Health Price Performance

Shares of LON PRTC opened at GBX 187.80 ($2.38) on Friday. The company has a current ratio of 6.76, a quick ratio of 2.51 and a debt-to-equity ratio of 29.57. PureTech Health plc has a twelve month low of GBX 139 ($1.76) and a twelve month high of GBX 238.50 ($3.03). The stock has a 50 day moving average of GBX 219.33 and a two-hundred day moving average of GBX 203.56. The stock has a market cap of £507.83 million, a P/E ratio of -988.42 and a beta of 0.93.

About PureTech Health

PureTech Health plc, a clinical-stage biopharma company, focuses on developing medicines for diseases caused by dysfunctions in the nervous, gastrointestinal, and immune systems. The company is developing a microbiome immune system drug-discovery platform and drug candidates for immune-mediated diseases; and products to induce weight loss and enhance glycaemic control through an orally administered capsule.